Dow Up 0.51% Nasdaq Up 0.24%

Celgene Corporation (CELG)

-NasdaqGS
108.20 Up 0.85(0.79%) Nov 21, 4:00PM EST
|After Hours : 108.50 Up 0.30 (0.28%) Nov 21, 6:40PM EST
Prev Close:107.35
Open:108.97
Bid:108.50 x 200
Ask:N/A
1y Target Est:112.09
Beta:2.02
Next Earnings Date:29-Jan-15CELG Earnings announcement
Day's Range:107.89 - 109.21
52wk Range:66.85 - 109.25
Volume:3,973,277
Avg Vol (3m):4,891,060
Market Cap:86.42B
P/E (ttm):56.68
EPS (ttm):1.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for CELG

Comparison

Symbol% ChgMkt Cap
CELGUp 0.79%86.42B
JNJUp 0.35%301.91B

Key Statistics

Forward P/E (1 yr):22.22
P/S (ttm):11.68
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):1.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback